DUBLIN, October 25, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Intravenous (IV) Solutions Market Analysis by Type And Segment Forecasts to 2024" report to their offering.
The global IV solutions market was valued at USD 6.9 billion in 2015 and is expected to reach a value of USD 13.79 billion by 2024. Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition.
The reimbursement scenario for IV nutrition is promising. In the U.S., Medicare covers up to 80% of the expenses of parenteral and enteral nutrition including physician services, medical equipment, and other related medical services. In the developing countries, increasing purchasing power compensates for the absence of reimbursement coverage thus sustaining the growth of this vertical.
TPN dominated the market in 2015. TPN is administered to patients who are nil by mouth' or are afflicted with dysfunctional digestive systems. Around 2000 elderly deaths occur per annum due to malnutrition. With rising geriatric population and chronic, but manageable diseases, the demand for TPN is projected to grow over the forecast period.
In 2015, North America dominated the market with a revenue share of around 40%. The region has a large geriatric population base comprising 45% long-term care residents and 40% hospitalized, elderly patients suffering from malnutrition. Moreover, in 2014, the region experienced a sharp shortage of IV fluids due to increased hospitalization of influenza patients. In response to the deficit, FDA initiatives were directed toward expediting the application review process and identifying potential new manufacturers.
Asia Pacific is expected to emerge as the fastest growing region. The rising geriatric population in Japan and China, increasing tendencies of unhealthy food consumption, and low level of awareness is expected to promote the emergence of IV solutions market in this region.
- Fresenius Kabi
- Sino-Swed Pharmaceutical Corp., Ltd.
- Amanta Healthcare
- Otsuka Pharmaceutical Co., Ltd.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Terumo Corporation
- B. Braun Melsungen AG
- Claris Lifesciences Ltd.
- Kyowa Hakko Bio Co., Ltd.
- Liqvor Pharmaceuticals
1 Research Methodology
2 Executive Summary
3 IV Solutions Industry Outlook
4 Market Categorization 1: Type Estimates & Trend Analysis
5 Market Categorization 2: Nutrient Estimates & Trend Analysis
6 Market Categorization 3: Regional Estimates & Trend Analysis, by Type & Nutrient
7 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/gtftn6/intravenous_iv
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-intravenous-iv-solutions-market-value-of-usd-1379-billion-by-2024---trends-technologies--opportunities-report-2016-2024---vendors-amanta-healthcare-grifols-terumo-300350792.html
SOURCE Research and Markets